| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $13.7M | -17.5% | -31.9% |
| SG&A Expense | $5.6M | -13.9% | -11.3% |
| Operating Income | -$19.4M | +16.5% | +27.0% |
| Pre-tax Income | -$10.0M | +61.5% | +57.8% |
| Income Tax | -$1.7M | -1510.2% | -896.2% |
| Net Income | -$8.4M | +68.0% | +65.1% |
| EPS (Basic) | -$0.13 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $30.7M | +9.0% | -61.8% |
| Current Assets | $36.8M | -5.5% | -57.3% |
| Total Assets | $40.0M | -5.6% | -55.6% |
| Current Liabilities | $18.3M | -8.0% | +14.1% |
| Long-term Debt | $16.7M | +148.0% | — |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$61.4M | — | — |
| Capital Expenditures | $58K | — | — |
| Investing Cash Flow | -$58K | — | — |
| Financing Cash Flow | $32.8M | — | — |
| Free Cash Flow | -$61.4M | — | — |
| +67.5% |
| +63.9% |
| EPS (Diluted) | -$0.13 | +67.5% | +63.9% |
| $39.0M |
| -4.1% |
| +124.7% |
| Stockholders' Equity | $911K | -42.8% | -98.7% |